1331888-08-4
1331888-08-4
Chemical Structure
SDMA-d6
Synonym(s): Symmetric dimethylarginine-d6;NG,NG'-Dimethyl-L-arginine-d6
- CAS No.: 1331888-08-4
- Formula:C8H12D6N4O2
- Molecular Weight:208.29
IUPAC Name: (S)-2-amino-5-((bis((methyl-d3)amino)methylene)amino)pentanoic acid
InChIKey: HVPFXCBJHIIJGS-BGUMHVNPSA-N
SMILES: OC([C@@H](N)CCC/N=C(NC([2H])([2H])[2H])/NC([2H])([2H])[2H])=O
Biological Activity: SDMA-d6 is the deuterium labeled SDMA. SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SDMA-d6 | 98.0% | SDMA-d6 is the deuterium labeled SDMA. SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SDMA (Standard) | ≥98% | SDMA (Standard) is the analytical standard of SDMA. This product is intended for research and analytical applications. SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity. SDMA, a novel kidney biomarker, permits earlier diagnosis of kidney disease than traditional creatinine testing. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SDMA | 98.0% | SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity. SDMA, a novel kidney biomarker, permits earlier diagnosis of kidney disease than traditional creatinine testing. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Bode-Böger SM,et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent ofcoronary artery disease. [Content Brief]
Keywords
